Literature DB >> 9721081

Controlled gene delivery by DNA-gelatin nanospheres.

V L Truong-Le1, J T August, K W Leong.   

Abstract

A novel system for gene delivery, based on the use of DNA-gelatin nanoparticles (nanospheres) formed by salt-induced complex coacervation of gelatin and plasmid DNA, has been developed. These particles were spherical, with a size range of 200-700 nm, contained 25-30% (w/w) DNA, and were stabilized by cross-linking of gelatin. As a consequence of being controlled by the cross-linking density of the gelatin matrix, the average release rate of DNA from nanospheres synthesized under standard conditions was 2.2%/day in serum. Nanosphere DNA incubated in bovine serum was more resistant to nuclease digestion than was naked DNA. Various bioactive agents could be encapsulated in the nanospheres by ionic interaction with the matrix components, physical entrapment, or covalent conjugation. Transfection of cultured cells with a luciferase plasmid was enhanced by conjugating human transferrin onto the nanosphere and coencapsulating the endolysolytic agent chloroquine. Under our experimental conditions, gene expression in mice subsequent to intramuscular injection of nanospheres containing 1 microg of a beta-galactosidase plasmid was greater and more prolonged than was observed after injection of an equal amount of naked DNA or DNA complexed with Lipofectamine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721081     DOI: 10.1089/hum.1998.9.12-1709

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  12 in total

1.  Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression.

Authors:  Jae-Hyung Jang; Lonnie D Shea
Journal:  J Control Release       Date:  2006-03-10       Impact factor: 9.776

2.  Evaluation and optimization of chitosan derivatives-based gene delivery system via kidney epithelial cells.

Authors:  S Safari; M H Zarrintan; M Soleimani; F A Dorkoosh; H Akbari; B Larijani; M Rafiee Tehrani
Journal:  Adv Pharm Bull       Date:  2012-02-15

Review 3.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

4.  Effects of Tissue-Type Plasminogen Site-Specific Transgene in Gelatin-Coated Dacron on the Fibrinolysis Activity of Rabbit Left Atrium.

Authors:  Xiaobin Liu; Kailun Zhang; Xionggang Jiang; Jiahong Xia; Daokang Xiang
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

5.  Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.

Authors:  Goldie Kaul; Mansoor Amiji
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

6.  Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery.

Authors:  Dongwon Lee; Weidong Zhang; Shawna A Shirley; Xiaoyuan Kong; Gary R Hellermann; Richard F Lockey; Shyam S Mohapatra
Journal:  Pharm Res       Date:  2006-11-14       Impact factor: 4.580

7.  Comparison of Different Crosslinking Methods for Preparation of Docetaxel-loaded Albumin Nanoparticles.

Authors:  Hassan Niknejad; Raziyeh Mahmoudzadeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

Review 8.  Immune Activities of Polycationic Vectors for Gene Delivery.

Authors:  Xiaotian Zhao; Xiaoming Li; Yi Zhao; Yuan Cheng; Yunqi Yang; Zhiwei Fang; Yangmei Xie; Yao Liu; Yinghui Chen; Yuanming Ouyang; Weien Yuan
Journal:  Front Pharmacol       Date:  2017-08-04       Impact factor: 5.810

9.  Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).

Authors:  Sonali Kumari; Saad M Ahsan; Jerald M Kumar; Anand K Kondapi; Nalam M Rao
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

Review 10.  Protein nanoparticles as drug delivery carriers for cancer therapy.

Authors:  Warangkana Lohcharoenkal; Liying Wang; Yi Charlie Chen; Yon Rojanasakul
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.